• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC NEUROSURGERY UNKNOWN STRATA VALVE/SHUNT; SHUNT, CENTRAL NERVOUS SYSTEM AND COMPONENTS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC NEUROSURGERY UNKNOWN STRATA VALVE/SHUNT; SHUNT, CENTRAL NERVOUS SYSTEM AND COMPONENTS Back to Search Results
Model Number UNKNOWN-S
Device Problem Infusion or Flow Problem (2964)
Patient Problems Wound Dehiscence (1154); Unspecified Infection (1930); Meningitis (2389)
Event Date 11/02/2020
Event Type  Injury  
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
Matheus fernandes de oliveira, a.A.Boa sorte jr, d.L.Emerenciano, j.M.Rotta, g.A.S.Mendes, f.C.G.Pinto.Long term follow-up of shunted idiopathic normal pressure hydrocephalus patients: a single center experience.Acta neurologica belgica (2020).Doi: 10.1007/s13760-020-01538-5 abstract idiopathic normal pressure hydrocephalus (inph) is a condition characterized by gait disturbance, dementia and/or urinary incontinence and enlarged ventricular system due to disturbance of cerebrospinal fluid (csf).This study aims to describe the long-term experience with patients with inph submitted to ventriculoperitoneal shunt (vps) with the programmable valve strata® (medtronic).We prospectively selected a cohort of patients with a diagnosis of inph from january 2010 to april 2013 in a brazilian tertiary hospital.All patients underwent clinical evaluation, which consists of the mini-mental state examination and time up and go tests and the application of japanese scale for idiopathic normal pressure hydrocephalus in three stages: prior to the tt, 3 h after the tt and 72 h after the tt.Fifty patients were submitted to vps and followed.There were 32 men and 18 women.Mean age was 77.1 with standard deviation of 10.9.Follow-up time ranged from 96 to 120 months, with mean of 106 months.After 1 year of follow-up, 42 (83%) patients presented with clinical improvement, decreasing to 62% of patients at mid-term follow-up and 38% of patients at late follow-up.Complications occurred in 18% of subjects, needing reoperation in 16%.Our results show relevant clinical impact of shunting in inph patients, decreasing over time.Complications should not be underestimated, reaching up to 18% and demanding reoperation in 16% of cases.Thus, although much has been improved with current shunt technology, it is still important to consider the drawbacks of treatment.Reported events.- subdural collections occurred in two patients.All were managed with surgical treatment.- malfunctioning of the valve forced the valve revision in two patients.- one patient presented with wound dehiscence and valve exposure after 6 months of the surgery, and it was necessary to remove the valve.- we had also two cases of shunt infection and meningitis which needed reoperation and antibiotics - there was a retroauricular wound dehiscence and shunt exposure which needed reoperation and valve change.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UNKNOWN STRATA VALVE/SHUNT
Type of Device
SHUNT, CENTRAL NERVOUS SYSTEM AND COMPONENTS
Manufacturer (Section D)
MEDTRONIC NEUROSURGERY
5290 california ave
irvine CA 92617
Manufacturer (Section G)
MEDTRONIC NEUROSURGERY
5290 california ave
irvine CA 92617
Manufacturer Contact
tricha miles
9775 toledo way
irvine, CA 92618
7635140379
MDR Report Key11233215
MDR Text Key229118032
Report Number2021898-2021-00028
Device Sequence Number1
Product Code JXG
Combination Product (y/n)N
Reporter Country CodeBR
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 01/26/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/26/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberUNKNOWN-S
Device Catalogue NumberUNKNOWN-S
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/04/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
-
-